These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


134 related items for PubMed ID: 3023492

  • 1. A human T cell line established from a patient with Sézary syndrome. Application for assay of human interleukin 2 (IL-2).
    Namiuchi S, Kumagai S, Sano H, Yodoi J, Uchiyama T, Ikai K, Imura H, Maeda M.
    J Immunol Methods; 1986 Nov 20; 94(1-2):215-24. PubMed ID: 3023492
    [Abstract] [Full Text] [Related]

  • 2. An OKT4+ T-cell population in Sézary syndrome: attempts to elucidate its lack of proliferative capacity and its suppressive effect.
    Golstein MM, Farnarier-Seidel C, Daubney P, Kaplanski S.
    Scand J Immunol; 1986 Jan 20; 23(1):53-64. PubMed ID: 3010442
    [Abstract] [Full Text] [Related]

  • 3. Application of a human T cell line derived from a Sézary syndrome patient for human interleukin 4 assay.
    Maeda M, Noma T, Hama K, Honjo T.
    Immunol Lett; 1988 Aug 20; 18(4):247-53. PubMed ID: 3263317
    [Abstract] [Full Text] [Related]

  • 4. Correlation between the phenotype and the functional capacity of activated T cells in patients with active systemic lupus erythematosus.
    Volk HD, Kopp J, Körner IJ, Jahn S, Grunow R, Barthelmes H, Fiebig H.
    Scand J Immunol; 1986 Jul 20; 24(1):109-14. PubMed ID: 3014641
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Characterization of T lymphocyte subpopulations responsible for deficient interleukin 2 activity in patients with systemic lupus erythematosus.
    Murakawa Y, Takada S, Ueda Y, Suzuki N, Hoshino T, Sakane T.
    J Immunol; 1985 Jan 20; 134(1):187-95. PubMed ID: 3917275
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Expression of interleukin 2 receptors on activated human B cells.
    Waldmann TA, Goldman CK, Robb RJ, Depper JM, Leonard WJ, Sharrow SO, Bongiovanni KF, Korsmeyer SJ, Greene WC.
    J Exp Med; 1984 Nov 01; 160(5):1450-66. PubMed ID: 6092511
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. IL-2- and IL-2-R- independent proliferation of T-cell lines from adult T-cell leukemia/lymphoma patients.
    Katoh T, Harada T, Morikawa S, Wakutani T.
    Int J Cancer; 1986 Aug 15; 38(2):265-74. PubMed ID: 2874115
    [Abstract] [Full Text] [Related]

  • 16. Study of activated T cells in man. II. Interleukin 2 receptor and transferrin receptor expression on T cells and production of interleukin 2 in patients with acquired immune deficiency syndrome (AIDS) and AIDS-related complex.
    Gupta S.
    Clin Immunol Immunopathol; 1986 Jan 15; 38(1):93-100. PubMed ID: 3000665
    [Abstract] [Full Text] [Related]

  • 17. Interleukin 2 regulates the expression of Tac antigen on peripheral blood T lymphocytes.
    Welte K, Andreeff M, Platzer E, Holloway K, Rubin BY, Moore MA, Mertelsmann R.
    J Exp Med; 1984 Nov 01; 160(5):1390-403. PubMed ID: 6092510
    [Abstract] [Full Text] [Related]

  • 18. Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factor.
    Waldmann TA, Greene WC, Sarin PS, Saxinger C, Blayney DW, Blattner WA, Goldman CK, Bongiovanni K, Sharrow S, Depper JM.
    J Clin Invest; 1984 Jun 01; 73(6):1711-8. PubMed ID: 6327770
    [Abstract] [Full Text] [Related]

  • 19. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
    Kabelitz D, Pfeffer K, von Steldern D, Bartmann P, Brudler O, Nerl C, Wagner H.
    J Immunol; 1985 Oct 01; 135(4):2876-81. PubMed ID: 2993419
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.